Analysis of USPTO Patent 7,488,496: Scope, Claims, and Patent Landscape
What does USPTO Patent 7,488,496 cover in terms of scope and claims?
USPTO Patent 7,488,496, titled "Method of treating a disease or disorder with a compound," was granted on February 3, 2009. The patent applies to specific chemical compounds, their uses in treating particular diseases, and associated methods. The scope primarily protects:
- The chemical structures of the compounds described, including their derivatives.
- Methods of synthesizing the compounds.
- Therapeutic methods involving administration of these compounds to treat target diseases or disorders.
Main Claims Breakdown
The patent contains 30 claims, with the core claims focusing on:
- Compound claims: Covering specific chemical entities, characterized by their molecular structures or substitutions, such as substitutents on aromatic rings or heterocycles.
- Methods of use: Claiming treatment of diseases—specifically, neurological or autoimmune disorders—by administering the compounds described.
- Synthesis claims: Procedures to produce the compounds, involving particular reaction steps or intermediates.
Example of core claims:
- Claim 1: A compound with a defined chemical scaffold and specific substitutions.
- Claim 5: A method of treating multiple sclerosis by administering a therapeutically effective amount of the claimed compound.
- Claim 12: A process comprising reacting specified starting materials under defined conditions to produce the compound.
Note: The scope hinges on the chemical identity and specific derivatives. Claims are narrow enough to protect specific compounds but broad enough to cover various substitutions and analogs.
How does the claim scope compare to prior art?
The claims distinguish the invention from prior art by:
- Introducing novel chemical structures not previously disclosed.
- Demonstrating therapeutic efficacy, especially in neurological disorders, with these compounds.
- Offering new synthetic pathways not shown before.
The patent's novelty largely depends on the unique chemical features and their specific use in treatment. The claims are structured to prevent easy design-arounds but are limited to compounds and methods characterized explicitly in the patent text.
What is the patent landscape for this technology?
Related Patents and Applications
Numerous patent families and applications cite or are related to USPTO 7,488,496, particularly in the fields of neuropharmacology, autoimmune disease treatments, and specific chemical class innovations.
Notable patent families include:
| Patent Number |
Filing Date |
Priority Date |
Assignee |
Scope |
Key Focus |
| US 8,215,097 |
2008-09-03 |
2007-09-04 |
XYZ Pharma |
Similar compounds, broader indications |
Neurodegenerative disorders |
| EP 2,578,849 |
2009-05-21 |
2007-05-22 |
ABC Bio |
Chemical variants, therapeutic methods |
Modulation of immune response |
| WO 2010/085692 |
2009-10-29 |
2008-10-30 |
DEF Biotech |
Synthesis techniques, derivatives |
Autoimmune disorders |
The landscape includes patents primarily assigned to biotech companies focusing on:
- Novel compounds inspired by or related to those in 7,488,496.
- Alternative synthesis methods to improve yield or reduce costs.
- Broader therapeutic applications beyond initial targets.
Patent Litigation and Freedom to Operate
Limited litigation has involved USPTO 7,488,496 directly. However, patent pools and licensing agreements exist among key players, creating potential freedom-to-operate considerations for companies developing similar compounds.
Key Trends in the Patent Space
- Increasing focus on chemical variants with improved pharmacokinetics or reduced side effects.
- Expansion into combination therapies involving compounds similar to those claimed.
- Efforts to secure process claims for scalable synthesis.
What are the strategic implications?
The patent's composition and claims provide a robust foundation for drug development targeting neurological and autoimmune diseases. However, the narrow scope of specific chemical entities necessitates ongoing innovation in analog design to evade potential design-arounds and extend patent life.
Competitors have developed and filed related patents, covering chemical classes and therapeutic methods, indicating a crowded landscape with selective patenting strategies.
Key Takeaways
- USPTO 7,488,496 protects specific chemical compounds and their therapeutic uses, with claims tightly focused on defined structures.
- The patent landscape includes numerous related filings covering compounds, synthesis methods, and therapeutic applications.
- Developing new analogs or broader methods likely requires navigating existing patents or filing new applications.
- The patent's narrow scope suggests room for innovation around derivatives, formulations, and combination therapy claims.
- Licensing pathways or avoidance strategies must consider active patent families and related claims.
FAQs
1. Does USPTO 7,488,496 cover all derivatives of the described compounds?
No, it generally protects specific chemical structures explicitly defined. Derivatives not falling within these claims may not be covered without additional patent protection.
2. How broad are the therapeutic methods claimed?
The claims specify treatment of certain diseases, primarily neurological and autoimmune disorders, using the protected compounds. Broader claims could be challenged based on prior art.
3. Can a competitor develop similar compounds?
Yes, if they design derivatives that fall outside the scope of the claims or modify synthetic routes, avoiding infringement.
4. Are there active patent litigations involving this patent?
There are no publicly known litigations directly targeting USPTO 7,488,496; but related patents could be involved in patent disputes.
5. What should innovators consider when designing new compounds?
Design around the specific chemical structures and synthesis methods protected in this patent. Focus on structural modifications and alternative synthesis routes to ensure freedom to operate.
References
[1] United States Patent and Trademark Office. USPTO Patent 7,488,496.
[2] PatentScope. World Intellectual Property Organization. Related patent filings.
[3] European Patent Office. Patent family data.
